Pictet Asset Management’s UroGen Pharma URGN Stock Holding History

Pictet Asset Management’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$258K	Buy	+7,000	New	+$190K	﹤0.01%	1849

Other funds holding URGN

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

KCM

Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return

Pictet Asset Management's URGN Position: Q2 2026 in Review

Pictet Asset Management opened a new position in UroGen Pharma (URGN) in Q2 2026: 7,000 shares worth $258K. The stake represents ﹤0.01% of the portfolio and ranks #1849 among its holdings.

25 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

Pictet Asset Management held 7,000 shares of UroGen Pharma worth $258K as of Q2 2026.
UroGen Pharma was a new Pictet Asset Management position in Q2 2026.
UroGen Pharma made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1849 holding.
25 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.